AI-generated summary
The authors retrospectively reviewed six eyes of five patients with atrophic age-related macular degeneration treated with multiwavelength photobiomodulation over three weeks. They report stable visual acuity, retinal thickness, sensitivity and atrophic area, no adverse effects, and an increase in a spectral autofluorescence signal at 575 nm. The study was a small, non-comparative case series.
- Participants
- 5
- Who or what was studied
- Five patients (six eyes) with atrophic age-related macular degeneration
- Wavelengths
- 575 nm
- Limits stated in the abstract
- Small, retrospective, non-comparative case series with no control group and only three months of follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 575 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Age-related macular degeneration, Biomarker, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.